181 related articles for article (PubMed ID: 30962261)
21. Overexpression of high mobility group box 1 with poor prognosis in patients after radical prostatectomy.
Li T; Gui Y; Yuan T; Liao G; Bian C; Jiang Q; Huang S; Liu B; Wu D
BJU Int; 2012 Dec; 110(11 Pt C):E1125-30. PubMed ID: 22672360
[TBL] [Abstract][Full Text] [Related]
22. Aberrant TIMELESS expression is associated with poor clinical survival and lymph node metastasis in early-stage cervical carcinoma.
Zhang W; He W; Shi Y; Zhao J; Liu S; Zhang F; Yang J; Xie C; Zhang Y
Int J Oncol; 2017 Jan; 50(1):173-184. PubMed ID: 27909716
[TBL] [Abstract][Full Text] [Related]
23. GINS2 is a novel prognostic biomarker and promotes tumor progression in early-stage cervical cancer.
Ouyang F; Liu J; Xia M; Lin C; Wu X; Ye L; Song L; Li J; Wang J; Guo P; He M
Oncol Rep; 2017 May; 37(5):2652-2662. PubMed ID: 28405687
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of Bmi-1 in uterine cervical cancer: correlation with clinicopathology and prognosis.
Zhang X; Wang CX; Zhu CB; Zhang J; Kan SF; Du LT; Li W; Wang LL; Wang S
Int J Gynecol Cancer; 2010 Dec; 20(9):1597-603. PubMed ID: 21370603
[TBL] [Abstract][Full Text] [Related]
25. Downregulation of HMGB1 by miR-34a is sufficient to suppress proliferation, migration and invasion of human cervical and colorectal cancer cells.
Chandrasekaran KS; Sathyanarayanan A; Karunagaran D
Tumour Biol; 2016 Oct; 37(10):13155-13166. PubMed ID: 27456356
[TBL] [Abstract][Full Text] [Related]
26. High Expression of Cell Division Cycle 42 Promotes Pancreatic Cancer Growth and Predicts Poor Outcome of Pancreatic Cancer Patients.
Yang D; Zhang Y; Cheng Y; Hong L; Wang C; Wei Z; Cai Q; Yan R
Dig Dis Sci; 2017 Apr; 62(4):958-967. PubMed ID: 28181096
[TBL] [Abstract][Full Text] [Related]
27. Filamin C promotes lymphatic invasion and lymphatic metastasis and increases cell motility by regulating Rho GTPase in esophageal squamous cell carcinoma.
Tanabe K; Shinsato Y; Furukawa T; Kita Y; Hatanaka K; Minami K; Kawahara K; Yamamoto M; Baba K; Mori S; Uchikado Y; Maemura K; Tanimoto A; Natsugoe S
Oncotarget; 2017 Jan; 8(4):6353-6363. PubMed ID: 28031525
[TBL] [Abstract][Full Text] [Related]
28. Identification and validation of the role of matrix metalloproteinase-1 in cervical cancer.
Tian R; Li X; Gao Y; Li Y; Yang P; Wang K
Int J Oncol; 2018 Apr; 52(4):1198-1208. PubMed ID: 29436615
[TBL] [Abstract][Full Text] [Related]
29. High-mobility group protein box1 expression correlates with peritumoral macrophage infiltration and unfavorable prognosis in patients with hepatocellular carcinoma and cirrhosis.
Zhang QB; Jia QA; Wang H; Hu CX; Sun D; Jiang RD; Zhang ZL
BMC Cancer; 2016 Nov; 16(1):880. PubMed ID: 27836008
[TBL] [Abstract][Full Text] [Related]
30. CCT6A may act as a potential biomarker reflecting tumor size, lymphatic metastasis, FIGO stage, and prognosis in cervical cancer patients.
Ma J; Yang L; Feng H; Zheng L; Meng H; Li X
J Clin Lab Anal; 2021 Aug; 35(8):e23793. PubMed ID: 34196992
[TBL] [Abstract][Full Text] [Related]
31. MicoRNA-425-5p is a potential prognostic biomarker for cervical cancer.
Sun L; Jiang R; Li J; Wang B; Ma C; Lv Y; Mu N
Ann Clin Biochem; 2017 Jan; 54(1):127-133. PubMed ID: 27166306
[TBL] [Abstract][Full Text] [Related]
32. Long non-coding RNA CCHE1 overexpression predicts a poor prognosis for cervical cancer.
Chen Y; Wang CX; Sun XX; Wang C; Liu TF; Wang DJ
Eur Rev Med Pharmacol Sci; 2017 Feb; 21(3):479-483. PubMed ID: 28239824
[TBL] [Abstract][Full Text] [Related]
33. Downregulation of HS6ST2 Inhibits Cervical Cancer Cell Migration and Invasion
Li S; Shen H; Wan Q; Chen P; Shu C; Wang H; Zhu W
Discov Med; 2023 Dec; 35(179):1147-1159. PubMed ID: 38058080
[TBL] [Abstract][Full Text] [Related]
34. GHET1 acts as a prognostic indicator and functions as an oncogenic lncRNA in cervical cancer.
Zhang Q; Zhang Y; Wang Y
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30948501
[TBL] [Abstract][Full Text] [Related]
35. Predictive significance of combined LAPTM4B and VEGF expression in patients with cervical cancer.
Meng F; Tan S; Liu T; Song H; Lou G
Tumour Biol; 2016 Apr; 37(4):4849-55. PubMed ID: 26526574
[TBL] [Abstract][Full Text] [Related]
36. Independent prognostic Factor of low-expressed LncRNA ZNF667-AS1 for cervical cancer and inhibitory function on the proliferation of cervical cancer.
Zhao LP; Li RH; Han DM; Zhang XQ; Nian GX; Wu MX; Feng Y; Zhang L; Sun ZG
Eur Rev Med Pharmacol Sci; 2017 Dec; 21(23):5353-5360. PubMed ID: 29243775
[TBL] [Abstract][Full Text] [Related]
37. Elevated Expression Levels of Long Non-Coding RNA, Loc554202, Are Predictive of Poor Prognosis in Cervical Cancer.
Chen J; Zhu J
Tohoku J Exp Med; 2017 Nov; 243(3):165-172. PubMed ID: 29129878
[TBL] [Abstract][Full Text] [Related]
38. MiR-1284 enhances sensitivity of cervical cancer cells to cisplatin via downregulating HMGB1.
Chen J; Li G
Biomed Pharmacother; 2018 Nov; 107():997-1003. PubMed ID: 30257412
[TBL] [Abstract][Full Text] [Related]
39. NR2F6 Expression Correlates with Pelvic Lymph Node Metastasis and Poor Prognosis in Early-Stage Cervical Cancer.
Niu C; Sun X; Zhang W; Li H; Xu L; Li J; Xu B; Zhang Y
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27775588
[TBL] [Abstract][Full Text] [Related]
40. High Mobility Group Box 1 (HMGB1) expression in gastric adenocarcinomas.
Suren D; Arda Gokay A; Sayiner A
J BUON; 2018; 23(2):422-427. PubMed ID: 29745087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
